APO Research
Talk to an analyst

APO RESEARCH · REPORT

Interleukin 1 Alpha

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Interleukin 1 Alpha Market Analysis and Forecast 2026-2032

19 December 2025192 pages

Choose your research edition.

Industry ResearchInterleukin 1 Alpha Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Interleukin 1 Alpha Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Interleukin 1 Alpha Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Interleukin 1 Alpha Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Interleukin 1 Alpha Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Interleukin 1 Alpha market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Interleukin 1 Alpha is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Interleukin 1 Alpha is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Interleukin 1 Alpha is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Interleukin 1 Alpha is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Interleukin 1 Alpha include Handok Inc, XBiotech Inc and AbbVie Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Interleukin 1 Alpha, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Interleukin 1 Alpha, also provides the sales of main regions and countries. Of the upcoming market potential for Interleukin 1 Alpha, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Interleukin 1 Alpha sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Interleukin 1 Alpha market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Interleukin 1 Alpha sales, projected growth trends, production technology, application and end-user industry.

Interleukin 1 Alpha Segment by Company

Handok Inc

XBiotech Inc

AbbVie Inc

Interleukin 1 Alpha Segment by Type

HL-2351

CV-18C3

ABT-981

Others

Interleukin 1 Alpha Segment by Application

Hospital

Clinic

Research Center

Interleukin 1 Alpha Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interleukin 1 Alpha market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Interleukin 1 Alpha and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interleukin 1 Alpha.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Interleukin 1 Alpha in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Interleukin 1 Alpha manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Interleukin 1 Alpha sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Interleukin 1 Alpha Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. HL-2351 Major Manufacturers Table 3. CV-18C3 Major Manufacturers Table 4. ABT-981 Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Interleukin 1 Alpha Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Research Center Major Manufacturers Table 10. Interleukin 1 Alpha Industry Trends Table 11. Interleukin 1 Alpha Industry Drivers Table 12. Interleukin 1 Alpha Industry Opportunities and Challenges Table 13. Interleukin 1 Alpha Industry Restraints Table 14. Global Interleukin 1 Alpha Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Interleukin 1 Alpha Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Interleukin 1 Alpha Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Interleukin 1 Alpha Revenue Market Share by Region (2021-2026) Table 18. Global Interleukin 1 Alpha Revenue Market Share by Region (2027-2032) Table 19. Global Interleukin 1 Alpha Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 20. Global Interleukin 1 Alpha Sales by Region (2021-2026) & (W Units) Table 21. Global Interleukin 1 Alpha Sales by Region (2027-2032) & (W Units) Table 22. Global Interleukin 1 Alpha Sales Market Share by Region (2021-2026) Table 23. Global Interleukin 1 Alpha Sales Market Share by Region (2027-2032) Table 24. Global Interleukin 1 Alpha Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Interleukin 1 Alpha Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Interleukin 1 Alpha Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Interleukin 1 Alpha Sales Market Share by Manufacturers (2021-2026) Table 28. Global Interleukin 1 Alpha Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Interleukin 1 Alpha Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Interleukin 1 Alpha Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Interleukin 1 Alpha Manufacturers, Product Type & Application Table 32. Global Interleukin 1 Alpha Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Interleukin 1 Alpha by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Interleukin 1 Alpha Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Interleukin 1 Alpha Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Interleukin 1 Alpha Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Interleukin 1 Alpha Revenue Market Share by Type (2021-2026) Table 39. Global Interleukin 1 Alpha Revenue Market Share by Type (2027-2032) Table 40. Global Interleukin 1 Alpha Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 41. Global Interleukin 1 Alpha Sales by Type (2021-2026) & (W Units) Table 42. Global Interleukin 1 Alpha Sales by Type (2027-2032) & (W Units) Table 43. Global Interleukin 1 Alpha Sales Market Share by Type (2021-2026) Table 44. Global Interleukin 1 Alpha Sales Market Share by Type (2027-2032) Table 45. Global Interleukin 1 Alpha Price by Type (2021-2026) & (US$/Unit) Table 46. Global Interleukin 1 Alpha Price by Type (2027-2032) & (US$/Unit) Table 47. Global Interleukin 1 Alpha Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Interleukin 1 Alpha Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Interleukin 1 Alpha Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Interleukin 1 Alpha Revenue Market Share by Application (2021-2026) Table 51. Global Interleukin 1 Alpha Revenue Market Share by Application (2027-2032) Table 52. Global Interleukin 1 Alpha Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 53. Global Interleukin 1 Alpha Sales by Application (2021-2026) & (W Units) Table 54. Global Interleukin 1 Alpha Sales by Application (2027-2032) & (W Units) Table 55. Global Interleukin 1 Alpha Sales Market Share by Application (2021-2026) Table 56. Global Interleukin 1 Alpha Sales Market Share by Application (2027-2032) Table 57. Global Interleukin 1 Alpha Price by Application (2021-2026) & (US$/Unit) Table 58. Global Interleukin 1 Alpha Price by Application (2027-2032) & (US$/Unit) Table 59. Handok Inc Company Information Table 60. Handok Inc Business Overview Table 61. Handok Inc Interleukin 1 Alpha Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Handok Inc Interleukin 1 Alpha Product Portfolio Table 63. Handok Inc Recent Development Table 64. XBiotech Inc Company Information Table 65. XBiotech Inc Business Overview Table 66. XBiotech Inc Interleukin 1 Alpha Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. XBiotech Inc Interleukin 1 Alpha Product Portfolio Table 68. XBiotech Inc Recent Development Table 69. AbbVie Inc Company Information Table 70. AbbVie Inc Business Overview Table 71. AbbVie Inc Interleukin 1 Alpha Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. AbbVie Inc Interleukin 1 Alpha Product Portfolio Table 73. AbbVie Inc Recent Development Table 74. North America Interleukin 1 Alpha Revenue by Type (2021-2026) & (US$ Million) Table 75. North America Interleukin 1 Alpha Revenue by Type (2027-2032) & (US$ Million) Table 76. North America Interleukin 1 Alpha Sales by Type (2021-2026) & (W Units) Table 77. North America Interleukin 1 Alpha Sales by Type (2027-2032) & (W Units) Table 78. North America Interleukin 1 Alpha Sales Price by Type (2021-2026) & (US$/Unit) Table 79. North America Interleukin 1 Alpha Sales Price by Type (2027-2032) & (US$/Unit) Table 80. North America Interleukin 1 Alpha Revenue by Application (2021-2026) & (US$ Million) Table 81. North America Interleukin 1 Alpha Revenue by Application (2027-2032) & (US$ Million) Table 82. North America Interleukin 1 Alpha Sales by Application (2021-2026) & (W Units) Table 83. North America Interleukin 1 Alpha Sales by Application (2027-2032) & (W Units) Table 84. North America Interleukin 1 Alpha Sales Price by Application (2021-2026) & (US$/Unit) Table 85. North America Interleukin 1 Alpha Sales Price by Application (2027-2032) & (US$/Unit) Table 86. North America Interleukin 1 Alpha Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Interleukin 1 Alpha Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 88. North America Interleukin 1 Alpha Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 89. North America Interleukin 1 Alpha Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 90. North America Interleukin 1 Alpha Sales by Country (2021-2026) & (W Units) Table 91. North America Interleukin 1 Alpha Sales by Country (2027-2032) & (W Units) Table 92. North America Interleukin 1 Alpha Sales Price by Country (2021-2026) & (US$/Unit) Table 93. North America Interleukin 1 Alpha Sales Price by Country (2027-2032) & (US$/Unit) Table 94. United States Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 95. Canada Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 96. Europe Interleukin 1 Alpha Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe Interleukin 1 Alpha Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe Interleukin 1 Alpha Sales by Type (2021-2026) & (W Units) Table 99. Europe Interleukin 1 Alpha Sales by Type (2027-2032) & (W Units) Table 100. Europe Interleukin 1 Alpha Sales Price by Type (2021-2026) & (US$/Unit) Table 101. Europe Interleukin 1 Alpha Sales Price by Type (2027-2032) & (US$/Unit) Table 102. Europe Interleukin 1 Alpha Revenue by Application (2021-2026) & (US$ Million) Table 103. Europe Interleukin 1 Alpha Revenue by Application (2027-2032) & (US$ Million) Table 104. Europe Interleukin 1 Alpha Sales by Application (2021-2026) & (W Units) Table 105. Europe Interleukin 1 Alpha Sales by Application (2027-2032) & (W Units) Table 106. Europe Interleukin 1 Alpha Sales Price by Application (2021-2026) & (US$/Unit) Table 107. Europe Interleukin 1 Alpha Sales Price by Application (2027-2032) & (US$/Unit) Table 108. Europe Interleukin 1 Alpha Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Interleukin 1 Alpha Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 110. Europe Interleukin 1 Alpha Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 111. Europe Interleukin 1 Alpha Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 112. Europe Interleukin 1 Alpha Sales by Country (2021-2026) & (W Units) Table 113. Europe Interleukin 1 Alpha Sales by Country (2027-2032) & (W Units) Table 114. Europe Interleukin 1 Alpha Sales Price by Country (2021-2026) & (US$/Unit) Table 115. Europe Interleukin 1 Alpha Sales Price by Country (2027-2032) & (US$/Unit) Table 116. Germany Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 117. France Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 118. U.K. Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 119. Italy Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 120. Netherlands Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 121. Nordic Countries Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 122. China Interleukin 1 Alpha Revenue by Type (2021-2026) & (US$ Million) Table 123. China Interleukin 1 Alpha Revenue by Type (2027-2032) & (US$ Million) Table 124. China Interleukin 1 Alpha Sales by Type (2021-2026) & (W Units) Table 125. China Interleukin 1 Alpha Sales by Type (2027-2032) & (W Units) Table 126. China Interleukin 1 Alpha Sales Price by Type (2021-2026) & (US$/Unit) Table 127. China Interleukin 1 Alpha Sales Price by Type (2027-2032) & (US$/Unit) Table 128. China Interleukin 1 Alpha Revenue by Application (2021-2026) & (US$ Million) Table 129. China Interleukin 1 Alpha Revenue by Application (2027-2032) & (US$ Million) Table 130. China Interleukin 1 Alpha Sales by Application (2021-2026) & (W Units) Table 131. China Interleukin 1 Alpha Sales by Application (2027-2032) & (W Units) Table 132. China Interleukin 1 Alpha Sales Price by Application (2021-2026) & (US$/Unit) Table 133. China Interleukin 1 Alpha Sales Price by Application (2027-2032) & (US$/Unit) Table 134. Asia Interleukin 1 Alpha Revenue by Type (2021-2026) & (US$ Million) Table 135. Asia Interleukin 1 Alpha Revenue by Type (2027-2032) & (US$ Million) Table 136. Asia Interleukin 1 Alpha Sales by Type (2021-2026) & (W Units) Table 137. Asia Interleukin 1 Alpha Sales by Type (2027-2032) & (W Units) Table 138. Asia Interleukin 1 Alpha Sales Price by Type (2021-2026) & (US$/Unit) Table 139. Asia Interleukin 1 Alpha Sales Price by Type (2027-2032) & (US$/Unit) Table 140. Asia Interleukin 1 Alpha Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Interleukin 1 Alpha Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Interleukin 1 Alpha Sales by Application (2021-2026) & (W Units) Table 143. Asia Interleukin 1 Alpha Sales by Application (2027-2032) & (W Units) Table 144. Asia Interleukin 1 Alpha Sales Price by Application (2021-2026) & (US$/Unit) Table 145. Asia Interleukin 1 Alpha Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Interleukin 1 Alpha Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Interleukin 1 Alpha Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. Asia Interleukin 1 Alpha Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. Asia Interleukin 1 Alpha Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 150. Asia Interleukin 1 Alpha Sales by Country (2021-2026) & (W Units) Table 151. Asia Interleukin 1 Alpha Sales by Country (2027-2032) & (W Units) Table 152. Asia Interleukin 1 Alpha Sales Price by Country (2021-2026) & (US$/Unit) Table 153. Asia Interleukin 1 Alpha Sales Price by Country (2027-2032) & (US$/Unit) Table 154. Japan Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 155. South Korea Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 156. India Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 157. Australia Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 158. China Taiwan Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 159. Southeast Asia Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 160. SAMEA Interleukin 1 Alpha Revenue by Type (2021-2026) & (US$ Million) Table 161. SAMEA Interleukin 1 Alpha Revenue by Type (2027-2032) & (US$ Million) Table 162. SAMEA Interleukin 1 Alpha Sales by Type (2021-2026) & (W Units) Table 163. SAMEA Interleukin 1 Alpha Sales by Type (2027-2032) & (W Units) Table 164. SAMEA Interleukin 1 Alpha Sales Price by Type (2021-2026) & (US$/Unit) Table 165. SAMEA Interleukin 1 Alpha Sales Price by Type (2027-2032) & (US$/Unit) Table 166. SAMEA Interleukin 1 Alpha Revenue by Application (2021-2026) & (US$ Million) Table 167. SAMEA Interleukin 1 Alpha Revenue by Application (2027-2032) & (US$ Million) Table 168. SAMEA Interleukin 1 Alpha Sales by Application (2021-2026) & (W Units) Table 169. SAMEA Interleukin 1 Alpha Sales by Application (2027-2032) & (W Units) Table 170. SAMEA Interleukin 1 Alpha Sales Price by Application (2021-2026) & (US$/Unit) Table 171. SAMEA Interleukin 1 Alpha Sales Price by Application (2027-2032) & (US$/Unit) Table 172. SAMEA Interleukin 1 Alpha Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. SAMEA Interleukin 1 Alpha Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. SAMEA Interleukin 1 Alpha Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. SAMEA Interleukin 1 Alpha Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 176. SAMEA Interleukin 1 Alpha Sales by Country (2021-2026) & (W Units) Table 177. SAMEA Interleukin 1 Alpha Sales by Country (2027-2032) & (W Units) Table 178. SAMEA Interleukin 1 Alpha Sales Price by Country (2021-2026) & (US$/Unit) Table 179. SAMEA Interleukin 1 Alpha Sales Price by Country (2027-2032) & (US$/Unit) Table 180. Brazil Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 181. Argentina Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 182. Chile Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 183. Colombia Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 184. Peru Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 185. Saudi Arabia Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 186. Israel Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 187. UAE Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 188. Turkey Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 189. Iran Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 190. Egypt Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Interleukin 1 Alpha Distributors List Table 194. Interleukin 1 Alpha Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Interleukin 1 Alpha Image Figure 2. Global Interleukin 1 Alpha Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Interleukin 1 Alpha Market Size Share 2021 VS 2025 VS 2032 Figure 4. HL-2351 Image Figure 5. CV-18C3 Image Figure 6. ABT-981 Image Figure 7. Others Image Figure 8. Global Interleukin 1 Alpha Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Interleukin 1 Alpha Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Research Center Image Figure 13. Global Interleukin 1 Alpha Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Interleukin 1 Alpha Revenue (2021-2032) & (US$ Million) Figure 15. Global Interleukin 1 Alpha Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Interleukin 1 Alpha Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Interleukin 1 Alpha Revenue Market Share by Region (2021-2032) Figure 18. Global Interleukin 1 Alpha Sales (2021-2032) & (W Units) Figure 19. Global Interleukin 1 Alpha Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 20. Global Interleukin 1 Alpha Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Interleukin 1 Alpha Sales YoY (2021-2032) & (W Units) Figure 22. Europe Interleukin 1 Alpha Sales YoY (2021-2032) & (W Units) Figure 23. China Interleukin 1 Alpha Sales YoY (2021-2032) & (W Units) Figure 24. Asia (Excluding China) Interleukin 1 Alpha Sales YoY (2021-2032) & (W Units) Figure 25. South America, Middle East and Africa Interleukin 1 Alpha Sales YoY (2021-2032) & (W Units) Figure 26. Global Interleukin 1 Alpha Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Interleukin 1 Alpha Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Interleukin 1 Alpha Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Interleukin 1 Alpha Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Interleukin 1 Alpha Revenue Market Share by Type (2021-2032) Figure 32. Global Interleukin 1 Alpha Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 33. Global Interleukin 1 Alpha Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Interleukin 1 Alpha Sales Market Share by Type (2021-2032) Figure 35. Global Interleukin 1 Alpha Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Interleukin 1 Alpha Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Interleukin 1 Alpha Revenue Market Share by Application (2021-2032) Figure 38. Global Interleukin 1 Alpha Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 39. Global Interleukin 1 Alpha Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Interleukin 1 Alpha Sales Market Share by Application (2021-2032) Figure 41. North America Interleukin 1 Alpha Revenue Share by Type (2021-2032) Figure 42. North America Interleukin 1 Alpha Sales Share by Type (2021-2032) Figure 43. North America Interleukin 1 Alpha Revenue Share by Application (2021-2032) Figure 44. North America Interleukin 1 Alpha Sales Share by Application (2021-2032) Figure 45. North America Interleukin 1 Alpha Revenue Share by Country (2021-2032) Figure 46. North America Interleukin 1 Alpha Sales Share by Country (2021-2032) Figure 47. Europe Interleukin 1 Alpha Revenue Share by Type (2021-2032) Figure 48. Europe Interleukin 1 Alpha Sales Share by Type (2021-2032) Figure 49. Europe Interleukin 1 Alpha Revenue Share by Application (2021-2032) Figure 50. Europe Interleukin 1 Alpha Sales Share by Application (2021-2032) Figure 51. Europe Interleukin 1 Alpha Revenue Share by Country (2021-2032) Figure 52. Europe Interleukin 1 Alpha Sales Share by Country (2021-2032) Figure 53. China Interleukin 1 Alpha Revenue Share by Type (2021-2032) Figure 54. China Interleukin 1 Alpha Sales Share by Type (2021-2032) Figure 55. China Interleukin 1 Alpha Revenue Share by Application (2021-2032) Figure 56. China Interleukin 1 Alpha Sales Share by Application (2021-2032) Figure 57. Asia Interleukin 1 Alpha Revenue Share by Type (2021-2032) Figure 58. Asia Interleukin 1 Alpha Sales Share by Type (2021-2032) Figure 59. Asia Interleukin 1 Alpha Revenue Share by Application (2021-2032) Figure 60. Asia Interleukin 1 Alpha Sales Share by Application (2021-2032) Figure 61. Asia Interleukin 1 Alpha Revenue Share by Country (2021-2032) Figure 62. Asia Interleukin 1 Alpha Sales Share by Country (2021-2032) Figure 63. SAMEA Interleukin 1 Alpha Revenue Share by Type (2021-2032) Figure 64. SAMEA Interleukin 1 Alpha Sales Share by Type (2021-2032) Figure 65. SAMEA Interleukin 1 Alpha Revenue Share by Application (2021-2032) Figure 66. SAMEA Interleukin 1 Alpha Sales Share by Application (2021-2032) Figure 67. SAMEA Interleukin 1 Alpha Revenue Share by Country (2021-2032) Figure 68. SAMEA Interleukin 1 Alpha Sales Share by Country (2021-2032) Figure 69. Interleukin 1 Alpha Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Interleukin 1 Alpha Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • HL-2351
  • CV-18C3
  • ABT-981
  • Others
Applications
  • Hospital
  • Clinic
  • Research Center
Companies covered
  • Handok Inc
  • XBiotech Inc
  • AbbVie Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Interleukin 1 Alpha Market by Type
  3. 1.2.1 Global Interleukin 1 Alpha Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 HL-2351
  5. 1.2.3 CV-18C3
  6. 1.2.4 ABT-981
  7. 1.2.5 Others
  8. 1.3 Interleukin 1 Alpha Market by Application
  9. 1.3.1 Global Interleukin 1 Alpha Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Research Center
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Interleukin 1 Alpha Market Dynamics
  1. 2.1 Interleukin 1 Alpha Industry Trends
  2. 2.2 Interleukin 1 Alpha Industry Drivers
  3. 2.3 Interleukin 1 Alpha Industry Opportunities and Challenges
  4. 2.4 Interleukin 1 Alpha Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Interleukin 1 Alpha Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Interleukin 1 Alpha Revenue by Region
  3. 3.2.1 Global Interleukin 1 Alpha Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Interleukin 1 Alpha Revenue by Region (2021-2026)
  5. 3.2.3 Global Interleukin 1 Alpha Revenue by Region (2027-2032)
  6. 3.2.4 Global Interleukin 1 Alpha Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Interleukin 1 Alpha Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Interleukin 1 Alpha Sales by Region
  9. 3.4.1 Global Interleukin 1 Alpha Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Interleukin 1 Alpha Sales by Region (2021-2026)
  11. 3.4.3 Global Interleukin 1 Alpha Sales by Region (2027-2032)
  12. 3.4.4 Global Interleukin 1 Alpha Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Interleukin 1 Alpha Revenue by Manufacturers
  2. 4.1.1 Global Interleukin 1 Alpha Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Interleukin 1 Alpha Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Interleukin 1 Alpha Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Interleukin 1 Alpha Sales by Manufacturers
  6. 4.2.1 Global Interleukin 1 Alpha Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Interleukin 1 Alpha Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Interleukin 1 Alpha Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Interleukin 1 Alpha Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Interleukin 1 Alpha Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Interleukin 1 Alpha Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Interleukin 1 Alpha Manufacturers, Product Type & Application
  13. 4.7 Global Interleukin 1 Alpha Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Interleukin 1 Alpha Market CR5 and HHI
  16. 4.8.2 2025 Interleukin 1 Alpha Tier 1, Tier 2, and Tier 3
5 Interleukin 1 Alpha Market by Type
  1. 5.1 Global Interleukin 1 Alpha Revenue by Type
  2. 5.1.1 Global Interleukin 1 Alpha Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Interleukin 1 Alpha Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Interleukin 1 Alpha Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Interleukin 1 Alpha Sales by Type
  6. 5.2.1 Global Interleukin 1 Alpha Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Interleukin 1 Alpha Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Interleukin 1 Alpha Sales Market Share by Type (2021-2032)
  9. 5.3 Global Interleukin 1 Alpha Price by Type
6 Interleukin 1 Alpha Market by Application
  1. 6.1 Global Interleukin 1 Alpha Revenue by Application
  2. 6.1.1 Global Interleukin 1 Alpha Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Interleukin 1 Alpha Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Interleukin 1 Alpha Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Interleukin 1 Alpha Sales by Application
  6. 6.2.1 Global Interleukin 1 Alpha Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Interleukin 1 Alpha Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Interleukin 1 Alpha Sales Market Share by Application (2021-2032)
  9. 6.3 Global Interleukin 1 Alpha Price by Application
7 Company Profiles
  1. 7.1 Handok Inc
  2. 7.1.1 Handok Inc Company Information
  3. 7.1.2 Handok Inc Business Overview
  4. 7.1.3 Handok Inc Interleukin 1 Alpha Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Handok Inc Interleukin 1 Alpha Product Portfolio
  6. 7.1.5 Handok Inc Recent Developments
  7. 7.2 XBiotech Inc
  8. 7.2.1 XBiotech Inc Company Information
  9. 7.2.2 XBiotech Inc Business Overview
  10. 7.2.3 XBiotech Inc Interleukin 1 Alpha Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 XBiotech Inc Interleukin 1 Alpha Product Portfolio
  12. 7.2.5 XBiotech Inc Recent Developments
  13. 7.3 AbbVie Inc
  14. 7.3.1 AbbVie Inc Company Information
  15. 7.3.2 AbbVie Inc Business Overview
  16. 7.3.3 AbbVie Inc Interleukin 1 Alpha Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 AbbVie Inc Interleukin 1 Alpha Product Portfolio
  18. 7.3.5 AbbVie Inc Recent Developments
8 North America
  1. 8.1 North America Interleukin 1 Alpha Market Size by Type
  2. 8.1.1 North America Interleukin 1 Alpha Revenue by Type (2021-2032)
  3. 8.1.2 North America Interleukin 1 Alpha Sales by Type (2021-2032)
  4. 8.1.3 North America Interleukin 1 Alpha Price by Type (2021-2032)
  5. 8.2 North America Interleukin 1 Alpha Market Size by Application
  6. 8.2.1 North America Interleukin 1 Alpha Revenue by Application (2021-2032)
  7. 8.2.2 North America Interleukin 1 Alpha Sales by Application (2021-2032)
  8. 8.2.3 North America Interleukin 1 Alpha Price by Application (2021-2032)
  9. 8.3 North America Interleukin 1 Alpha Market Size by Country
  10. 8.3.1 North America Interleukin 1 Alpha Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Interleukin 1 Alpha Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Interleukin 1 Alpha Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Interleukin 1 Alpha Market Size by Type
  2. 9.1.1 Europe Interleukin 1 Alpha Revenue by Type (2021-2032)
  3. 9.1.2 Europe Interleukin 1 Alpha Sales by Type (2021-2032)
  4. 9.1.3 Europe Interleukin 1 Alpha Price by Type (2021-2032)
  5. 9.2 Europe Interleukin 1 Alpha Market Size by Application
  6. 9.2.1 Europe Interleukin 1 Alpha Revenue by Application (2021-2032)
  7. 9.2.2 Europe Interleukin 1 Alpha Sales by Application (2021-2032)
  8. 9.2.3 Europe Interleukin 1 Alpha Price by Application (2021-2032)
  9. 9.3 Europe Interleukin 1 Alpha Market Size by Country
  10. 9.3.1 Europe Interleukin 1 Alpha Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Interleukin 1 Alpha Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Interleukin 1 Alpha Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Interleukin 1 Alpha Market Size by Type
  2. 10.1.1 China Interleukin 1 Alpha Revenue by Type (2021-2032)
  3. 10.1.2 China Interleukin 1 Alpha Sales by Type (2021-2032)
  4. 10.1.3 China Interleukin 1 Alpha Price by Type (2021-2032)
  5. 10.2 China Interleukin 1 Alpha Market Size by Application
  6. 10.2.1 China Interleukin 1 Alpha Revenue by Application (2021-2032)
  7. 10.2.2 China Interleukin 1 Alpha Sales by Application (2021-2032)
  8. 10.2.3 China Interleukin 1 Alpha Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Interleukin 1 Alpha Market Size by Type
  2. 11.1.1 Asia Interleukin 1 Alpha Revenue by Type (2021-2032)
  3. 11.1.2 Asia Interleukin 1 Alpha Sales by Type (2021-2032)
  4. 11.1.3 Asia Interleukin 1 Alpha Price by Type (2021-2032)
  5. 11.2 Asia Interleukin 1 Alpha Market Size by Application
  6. 11.2.1 Asia Interleukin 1 Alpha Revenue by Application (2021-2032)
  7. 11.2.2 Asia Interleukin 1 Alpha Sales by Application (2021-2032)
  8. 11.2.3 Asia Interleukin 1 Alpha Price by Application (2021-2032)
  9. 11.3 Asia Interleukin 1 Alpha Market Size by Country
  10. 11.3.1 Asia Interleukin 1 Alpha Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Interleukin 1 Alpha Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Interleukin 1 Alpha Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Interleukin 1 Alpha Market Size by Type
  2. 12.1.1 SAMEA Interleukin 1 Alpha Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Interleukin 1 Alpha Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Interleukin 1 Alpha Price by Type (2021-2032)
  5. 12.2 SAMEA Interleukin 1 Alpha Market Size by Application
  6. 12.2.1 SAMEA Interleukin 1 Alpha Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Interleukin 1 Alpha Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Interleukin 1 Alpha Price by Application (2021-2032)
  9. 12.3 SAMEA Interleukin 1 Alpha Market Size by Country
  10. 12.3.1 SAMEA Interleukin 1 Alpha Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Interleukin 1 Alpha Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Interleukin 1 Alpha Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Interleukin 1 Alpha Value Chain Analysis
  2. 13.1.1 Interleukin 1 Alpha Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Interleukin 1 Alpha Production Mode & Process
  6. 13.2 Interleukin 1 Alpha Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Interleukin 1 Alpha Distributors
  9. 13.2.3 Interleukin 1 Alpha Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst